Related references
Note: Only part of the references are listed.Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents
Mostafa M. Ghorab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries
Aural Kamal Abdel-Aziz et al.
EXPERIMENTAL NEUROLOGY (2016)
Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Hypoxia as a biomarker for radioresistant cancer stem cells
Claudia Peitzsch et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
Hypoxia Enhances the Radioresistance of Mouse Mesenchymal Stromal Cells
Tara Sugrue et al.
STEM CELLS (2014)
Syntheses and biological activity of chalcones-imidazole derivatives
Yu-Ting Liu et al.
RESEARCH ON CHEMICAL INTERMEDIATES (2013)
Cytotoxic activity evaluation and QSAR study of chromene-based chalcones
Loghman Firoozpour et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations
Camila Munoz et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents
Dalal A. Abou El Ella et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties
John J. Haddad
SAUDI PHARMACEUTICAL JOURNAL (2012)
Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Y. Shan et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Biological evaluation of synthetic analogues of curcumin: chloro-substituted-2′-hydroxychalcones as potential inhibitors of tubulin polymerization and cell proliferation
Hassan Aryapour et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth
Cassia S. Mizuno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and anticancer evaluation of thiazolyl-chalcones
Hai-Bo Shi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors
Ping Lan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Identification of Potent Pyrazolo[4,3-h]quinazoline-3-carboxamides as Multi-Cyclin-Dependent Kinase Inhibitors
Gabriella Traquandi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Chalcones in Cancer: Understanding their Role in Terms of QSAR
A. -M. Katsori et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor
Maria Gabriella Brasca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
N-Phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents
Lidia Matesic et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2′,5′-dialkoxylchalcones as cancer chemopreventive agents
Jen-Hao Cheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Seven new prenylated indole diketopiperazine alkaloids from holothurian-derived fungus Aspergillus fumigatus
Fazuo Wang et al.
TETRAHEDRON (2008)
Vascular disrupting agents in clinical development
P. Hinnen et al.
BRITISH JOURNAL OF CANCER (2007)
Design, synthesis, and antiproliferative and CDK2-cyclin A inhibitory activity of novel flavopiridol analogues
Yu Mi Ahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines
Maximiliano Sortino et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives
Hai-hong Li et al.
ACTA PHARMACOLOGICA SINICA (2007)
The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism
Ning Gao et al.
MOLECULAR PHARMACOLOGY (2006)
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity
Shem Patyna et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Anticancer activities of novel chalcone and bis-chalcone derivatives
A Modzelewska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells
KG Daniel et al.
BIOCHEMICAL PHARMACOLOGY (2004)
In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model
P Marzola et al.
CLINICAL CANCER RESEARCH (2004)
Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors
XY Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models
JG Ma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Share Paper
